A novel approach to preventing diabetic ketoacidosis in a patient treated with an insulin pump

Diabetes Care

Volumn 26, Issue 10, 2003, Pages 2960-2961

  Phillips, Ben D ^a,b,c   Aurand, Lisa A ^a,b   Bedwell, Michele M ^a   Levy, James R ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Department of Endocrinology 111P ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN GLARGINE;

ADULT; ARTICLE; CASE REPORT; CONTINUOUS INFUSION; DIABETIC KETOACIDOSIS; DRUG DELIVERY SYSTEM; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN PUMP; MALE; QUALITY OF LIFE; TREATMENT OUTCOME;

DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED;

EID: 0141446218     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.26.10.2960     Document Type: Article

References (4)

1. Pickup JC, Viberti GC, Bilous RW: Safety of continuous subcutaneous insulin infusion: metabolic deterioration and glycaemic autoregulation after deliberate cessation of infusion. Diabetologia 22:175-179, 1992
2. Lepore M, Pampanelli S, Fanelli C, Porcellati F, Bartocci L, Di Vincenzo A, Cordoni C, Costa E, Brunetti P, Bolli GB: Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 49:2142-2148, 2000
3. Heinemann L, Linkeschova R, Rave K, Hompesch B, Sedlak M, Heise T: Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo. Diabetes Care 23:644-649
4. Bending JJ, Pickup JC, Keen H: Frequency of diabetic ketoacidosis and hypoglycemic coma during treatment with continuous subcutaneous insulin infusion. Am J Med 79:685-691, 1985